Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for receptors tumor necrosis factor, type i (compound)
Most Correlated Studies
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Most Relevant Literature
- The 12-Membered TNFR1 Peptide, as Well as the 16-Membered and 6-Membered TNF Peptides, Regulate TNFR…
- Absence of TNFR1 promotes a protective response in the early phase of hepatic encephalopathy induced…
- TNF-α-TNFR1 Signaling Mediates Inflammation and Bone Resorption in Apical Periodontitis.
- Autoimmune Valvular Carditis Requires Endothelial Cell TNFR1 Expression.
- Acute Kidney Injury-Induced Circulating TNFR1/2 Elevations Correlate with Persistent Kidney Injury a…
Most Relevant Clinical Trials
- Glucocorticoid-induced Tumour Necrosis Factor Receptor Related Protein (GITR) in Rheumatoid Arthriti…
- A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors
- A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma
- Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors
- NeoTIL in Advanced Solid Tumors
